Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia. [electronic resource]
Producer: 20110714Description: 724-5 p. digitalISSN:- 1029-2403
- Antineoplastic Agents -- therapeutic use
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- complications
- Male
- Middle Aged
- Platelet Count
- Receptors, Fc -- therapeutic use
- Receptors, Thrombopoietin -- agonists
- Recombinant Fusion Proteins -- therapeutic use
- Thrombocytopenia -- complications
- Thrombopoietin -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.